4//SEC Filing
Asterias Biotherapeutics, Inc. 4
Accession 0001140361-17-026471
CIK 0001572552operating
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 4:05 PM ET
Size
6.9 KB
Accession
0001140361-17-026471
Insider Transaction Report
Form 4
Cartt Stephen LaHue
DirectorPresident and CEO
Transactions
- Award
Stock Options
2017-06-26+20,000→ 20,000 totalExercise: $3.70Exp: 2027-06-26→ Common Stock (20,000 underlying)
Holdings
- 292,783
Common Stock
- 375,000
Stock Options
Exercise: $3.64Exp: 2026-02-28→ Common Stock (375,000 underlying)
Footnotes (2)
- [F1]Subject to Mr. Cartt's continued service on the Board of the Company, the stock options over four equal quarterly installments beginning on July 1, 2017. The stock options are exercisable upon vesting.
- [F2]Of such stock options, 62,500 have not vested as of the date hereof.
Documents
Issuer
Asterias Biotherapeutics, Inc.
CIK 0001572552
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001572552
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 4:05 PM ET
- Size
- 6.9 KB